Pilot Funding
ITHS Technology Access Grants
The new Institute of Translational Health Sciences (ITHS) is funded by the National Institutes
of Health (NIH) Clinical and Translational Science Award (CTSA), which NIH awarded us on
September 17, 2007.
This new program aims to unite scientists at the University of Washington, Fred Hutchinson
Cancer Research Center, Children's Hospital and Regional Medical Center and other partner
institutions, to advance and transform clinical and translational science.
The ITHS is pleased to announce the opportunity to apply for modest "technology access"
grants. These grants will cover costs associated with the provision of services to you through an
ITHS-approved facility core, shared resource, or cost center.
The aims of the technology access grants are to:
- Support the incorporation of new technologies into translational and clinical research.
- Foster collaborations between approved applicants and technology service providers.
- Encourage the utilization of the latest technologies and instrumentation into translational and clinical research.
- Promote the career development of junior faculty members in the ITHS.
Technology Access Grants information:
- Up to $10,000 per accepted applicant will be directly applied to the costs of the ITHS-approved facility core, shared resource or cost center.
- Applications are due no later than May 1, 2008, 11:59 PM.
- The ITHS will pay the service provider directly.
Grant Eligibility, please refer to the technology examples page for specific examples of approved
technology, found here:
- Any faculty member or faculty-level researcher is eligible to apply
- Special priority will be given to junior faculty with limited funding.
- Special consideration will be given to first-time applicants.
- The technology used in the proposal must be provided by an ITHS-approved technology service provider. A list of potential providers can be accessed via the links below. Utilization of resources not identified on these lists is also encouraged; contact ITHS staff in advance to discuss options.
- The technology must be reasonably new to your own research program (i.e., these funds are not intended to subsidize continuing use of technologies).
- The proposed research that will benefit the new technology must be readily identifiable as either "translational" or "clinical" in nature ((these funds are not intended to support basic research; see below for definitions of clinical and translational research).
- The Principal Investigator (PI) will be responsible for clearly defining on the application how the proposed research has the potential to lead to direct applications in human health (e.g., prevention, diagnosis, treatment or assessment of a human disease or health outcome).
- The PI is responsible for clearly describing how the new technology will provide a unique advantage to the proposed research.
- The PI is responsible for discussing the study design with the technology service provider in detail before submitting the application. Doing so ensures the new technology is appropriate for the needs of the PI and identifies the technology service provider as capable of delivering the required services in the appropriate time with consideration to cost limitations, as identified in the application.
Download ITHS Technology Access Grant Application
Please read the detailed application instructions found
here.
Complete the application, and convert it to pdf format. Then e-mail the completed application to Kathy Long at
ithsapps@u.washington.edu
Applications must be received by May 1, 2008, 11:59PM. Unsigned applications,
or those not following the required format will be returned.
Links to ITHS-approved service providers:
If you would like to recommend additional service providers, please send the
information to
ithsapps@u.washington.edu
For more information regarding the application process contact Kathy Long at
ithsapps@u.washington.edu or
by phone at 206-598-4700.